In some individuals herpes simplex recrudesces periodically and between attacks the virus lies dormant (latent) in sensory neurons of the peripheral nervous system (1, 2) . There are many potential reasons for individual variation in the natural history of herpes simplex. Prominent aspects are variation in the phenotype of different HSV strains and the ability of the individual host to contain the infection. With respect to the latter, both innate resistance and adaptive immunity have been extensively studied, particularly in animal models of the disease.
SIMMONS
BRIEF DEFINITIVE REPORT which results in an acute ganglionic infection by centripetal spread of virus along sensory nerves, resembling the spread of virus to the human nervous system . Third, differences between the mouse strains were judged quantitatively, according to the amount of infectious virus recovered from the sensory dorsal root ganglia .
* Range . S No data owing to death of mice .
Materials and Methods
Mice. Female mice were used at 6-8 wk of age . C57B10 (H-2 6), B10.D2 (H-2d), B10 .Br (H-2 k), and B10 .A (H-2ktd) were obtained from the specific pathogen-free facility, Animal Resource Centre, Perth, Western Australia.
Virus . A well-characterized clone of a low passaged oral isolate of HSV type 1, strain SC16, was used (7) . This virus is moderately virulent in mice (8) . Stocks were grown in BHK-21 cells and stored at -70°C .
Infection of Mice. The zosteriform model used in these experiments has been described in detail elsewhere (9) . Briefly, after depilation with Nair (Carter-Wallace, NSW, Australia), a small patch of skin on the left flank was scarified with a 27-guage needle through a 10-J1 drop of virus suspension containing 5 x 104 plaque forming units (pfu) .
Titration of Virus in Tissue Samples. The eighth to thirteenth left thoracic dorsal root ganglia were removed and stored at -70°C until required . The pooled ganglia from each mouse were homogenized in a 1-ml glass tissue grinder (Wheaton Industries, Millville, NJ) and 10-fold dilutions of the homogenate were tested for presence of infectious virus using a standard plaque assay (10) .
Results and Discussion
Groups of H-2 congenic mice were studied 5, 7, 9, and 11 d after infection with HSV (Table I) In a similar experiment ( Fig . 1) , focusing on the seventh day after infection, concordant results were obtained . Logo pfuperganglion These data show that C57BL10 H-2 congenic mice vary in their ability to control the spread 'of virus within the peripheral nervous system during the period 5-9 d after infection with a moderate dose of SC16 . Virus clearance from the ganglia commenced between the fifth and seventh day after infection in H-2b (C57B10 parent strain) and H-2d (C57B10.D2) mice, but not in H-2k (C57B10 .Br) animals. Mice of the latter haplotype were sufficiently compromised in their ability to control the disease for a fatal infection to develop, despite the innate resistance expected of the C57B10 background . C57B10 .A mice, which are a natural intra-H-2 k/d recombinant, behaved in an intermediate fashion, suggesting that the introduction of k genes at the K and IA loci is sufficient to reduce the ability of the animals to control the infection at this critical period, when the specific immune response is becoming effective . In this context the finding ofjennings et al . (11) , that cytotoxic T cells preferentially see HSV antigens in association with H-2K rather than H-2D, may be relevant .
Overall, the ability to control a challenge with herpes simplex has two elements . First, there is powerful innate resistance to infection, which was first demonstrated by Lopez (3) , and is mediated by as yet unknown mechanisms, and second, there is an MHC-linked phase, during which certain hosts (such as C57B10 .Br mice) may be significantly compromised in their ability to initiate optimum clearance of virus from the nervous system . The extent to which the nervous system is involved during primary infection may influence the subsequent behavior of the disease, because the ganglia are the main reservoir of infection between recurrences.
Attempts in humans to find HLA types that are associated with severe or frequently recurrent herpes simplex have been disappointing, although some weak associations have been reported (12, 13) . However, against a variable background of powerful innate resistance genes and variations in the neurovirulence of different HSV strains (14) , the chance of discovering MHC-linked effects using population studies is predictably very low. Even in studies using inbred mice, differences between H-2 haplotypes of two to three orders of magnitude have been overlooked until now.
Immunological hyporesponsiveness (in the form of a poor CTL response) to whole influenza virus proteins has recently been demonstrated in association with certain mouse H-2 haplotypes (15) . The large variation in the response of H-2' and H-2d mice to challenge with HSV could therefore be the result of a defect in the specific Variation of two to three orders of magnitude in the ability of different inbred H-2 congenic mice to control HSV infection demonstrates the importance of genetic diversity with respect to the MHC in outbred populations . Challenge with infectious agents could of course be a significant selective force in maintaining such diversity.
Summary
Infection of the peripheral nervous system was studied after inoculation of HSV into the flank skin of H-2 congenic mice. The amount of virus recovered from the sensory ganglia varied significantly between the mouse strains tested . Differences became apparent 7 d after infection, at which time the severity of disease in H-2k mice was two to three orders of magnitude greater than that in H-2 d animals .
The association of the H-2 k haplotype with impaired ability to clear HSV from the nervous system is the first clear demonstration that genes within the MHC can influence the severity of primary herpetic infection, in spite of numerous studies on genetic resistance to this disease .
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